VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1613140
Sex: M
Age: 78
State: CA

Vax Date: 01/23/2021
Onset Date: 02/02/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: had a blood vessel burst in his leg; felt he did not have any strength; pain in arm/shoulder; maybe arthritis which he never felt in shoulder; Could not raise his arm over his head; Pain then travelled to the other arm; It became so bad that he could not use his arm without pain; This spontaneous case was reported by a consumer and describes the occurrence of VASCULAR INJURY (had a blood vessel burst in his leg), INJECTION SITE MUSCLE WEAKNESS (felt he did not have any strength), PAIN IN EXTREMITY (pain in arm/shoulder), ARTHRITIS (maybe arthritis which he never felt in shoulder) and PAIN (It became so bad that he could not use his arm without pain) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 027C20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No relevant medical history reported. Concomitant products included ACYCLOVIR SODIUM, MELOXICAM, TERAZOSIN and ATORVASTATIN for an unknown indication. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced PAIN (It became so bad that he could not use his arm without pain). On 20-Feb-2021, the patient experienced INJECTION SITE MUSCLE WEAKNESS (felt he did not have any strength), PAIN IN EXTREMITY (pain in arm/shoulder), ARTHRITIS (maybe arthritis which he never felt in shoulder), MOBILITY DECREASED (Could not raise his arm over his head) and ARTHRALGIA (Pain then travelled to the other arm). On 27-Apr-2021, the patient experienced VASCULAR INJURY (had a blood vessel burst in his leg). The patient was treated with NAPROXEN for Adverse event, at a dose of 1 dosage form; ACETAMINOPHEN at a dose of 1 dosage form and IBUPROFEN for Adverse event, at a dose of 1 dosage form. At the time of the report, VASCULAR INJURY (had a blood vessel burst in his leg), INJECTION SITE MUSCLE WEAKNESS (felt he did not have any strength), ARTHRITIS (maybe arthritis which he never felt in shoulder), PAIN (It became so bad that he could not use his arm without pain), MOBILITY DECREASED (Could not raise his arm over his head) and ARTHRALGIA (Pain then travelled to the other arm) outcome was unknown and PAIN IN EXTREMITY (pain in arm/shoulder) had not resolved. This case was linked to MOD-2021-100500 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Significant Follow-up :- patient confirmed regarding events that his arm is still hurting.

Other Meds: ACYCLOVIR SODIUM; MELOXICAM; TERAZOSIN; ATORVASTATIN

Current Illness:

ID: 1613141
Sex: F
Age:
State: NY

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Colo:Pinkish Purplish; Warmth; Arm soreness; Rash; nausea; Feeling anxious; Hot flushes; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Feeling anxious), HOT FLUSH (Hot flushes), VACCINATION SITE DISCOLOURATION (Colo:Pinkish Purplish), VACCINATION SITE WARMTH (Warmth) and PAIN IN EXTREMITY (Arm soreness) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B2 1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced ANXIETY (Feeling anxious), HOT FLUSH (Hot flushes) and NAUSEA (nausea). On 08-Apr-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Colo:Pinkish Purplish), VACCINATION SITE WARMTH (Warmth), PAIN IN EXTREMITY (Arm soreness) and RASH (Rash). At the time of the report, ANXIETY (Feeling anxious), HOT FLUSH (Hot flushes), VACCINATION SITE DISCOLOURATION (Colo:Pinkish Purplish), VACCINATION SITE WARMTH (Warmth), PAIN IN EXTREMITY (Arm soreness), RASH (Rash) and NAUSEA (nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1613142
Sex: F
Age: 70
State: IA

Vax Date: 03/29/2021
Onset Date: 04/12/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tightness in the back of both knees; This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (Tightness in the back of both knees) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020-821A) for COVID-19 vaccination. Concurrent medical conditions included Varicose veins. Concomitant products included ATENOLOL for Blood pressure abnormal, OMEPRAZOLE for Gastric acid increased, Albuterol and MULTIVITAMIN [VITAMINS NOS] for an unknown indication. On 29-Mar-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced JOINT STIFFNESS (Tightness in the back of both knees). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, JOINT STIFFNESS (Tightness in the back of both knees) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: ATENOLOL; OMEPRAZOLE; Albuterol; MULTIVITAMIN [VITAMINS NOS]

Current Illness: Varicose veins

ID: 1613143
Sex: F
Age: 44
State: GA

Vax Date: 04/03/2021
Onset Date: 05/01/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; some vaccine leaked out; Syringe snapped; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), UNDERDOSE (some vaccine leaked out) and DEVICE CONNECTION ISSUE (Syringe snapped) in a 44-year-old female patient who received mRNA-1273 (batch nos. 016C21A and 030B21A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No adverse event nor concomitant medications were reported.). On 03-Apr-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Intramuscular) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced PAIN IN EXTREMITY (sore arm), UNDERDOSE (some vaccine leaked out) and DEVICE CONNECTION ISSUE (Syringe snapped). On 01-May-2021, UNDERDOSE (some vaccine leaked out) and DEVICE CONNECTION ISSUE (Syringe snapped) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. The action taken with mRNA-1273 (Intramuscular) was not applicable. Patient reports that while receiving her second dose of Moderna COVID-19 vaccine the syringe snapped and some vaccine leaked out.

Other Meds:

Current Illness:

ID: 1613144
Sex: M
Age: 66
State: LA

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: received first dose of vaccine 18Mar2021. Has not received second dose.; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received first dose of vaccine 18Mar2021. Has not received second dose.) in a 66-year-old male patient who received mRNA-1273 (batch no. 031a21a) for COVID-19 vaccination. No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received first dose of vaccine 18Mar2021. Has not received second dose.). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received first dose of vaccine 18Mar2021. Has not received second dose.) had resolved. The action taken with mRNA-1273 (Unknown) was unknown. For mRNA-1273 (Unknown), the reporter did not provide any causality assessments. Pharmacist is calling for her patient who received his first dose of the Moderna vaccine 43 days ago. His 1st dose was on 18Mar2021 Lot number 031a21a. No concomitant medication and treatment provided

Other Meds:

Current Illness:

ID: 1613145
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lost taste after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Lost taste after 2nd dose) in a 53-year-old female patient who received mRNA-1273 for COVID-19 immunisation. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Intramuscular) 1 dosage form. On an unknown date, the patient experienced AGEUSIA (Lost taste after 2nd dose). At the time of the report, AGEUSIA (Lost taste after 2nd dose) outcome was unknown. No treatment information was provided. No concomitant medication was provided.

Other Meds:

Current Illness:

ID: 1613146
Sex: M
Age: 54
State: PA

Vax Date: 04/29/2021
Onset Date: 04/30/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: he was dizzy; he almost passed out; He was sore; he got a fever; Very tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (he was dizzy), PRESYNCOPE (he almost passed out), MYALGIA (He was sore), PYREXIA (he got a fever) and FATIGUE (Very tired) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced DIZZINESS (he was dizzy), PRESYNCOPE (he almost passed out), MYALGIA (He was sore), PYREXIA (he got a fever) and FATIGUE (Very tired). At the time of the report, DIZZINESS (he was dizzy), PRESYNCOPE (he almost passed out), MYALGIA (He was sore), PYREXIA (he got a fever) and FATIGUE (Very tired) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided by reporter.

Other Meds:

Current Illness:

ID: 1613147
Sex: F
Age: 31
State: NY

Vax Date: 04/30/2021
Onset Date: 04/30/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pregnant and received Vaccine; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant and received Vaccine) in a 31-year-old female patient who received mRNA-1273 (batch no. 046B21A) for COVID-19 vaccination. No Medical History information was reported. On 30-Apr-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. The patient's last menstrual period was in November 2020 and the estimated date of delivery was date. On 30-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant and received Vaccine). The patient received mRNA-1273 during pregnancy. On 30-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant and received Vaccine) had resolved. The action taken with mRNA-1273 (Intramuscular) was unknown. For mRNA-1273 (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication details was reported. No treatment medication details was reported. The patient was 27 weeks pregnant at the time of vaccination.

Other Meds:

Current Illness:

ID: 1613148
Sex: M
Age: 16
State: TX

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Patient under 18 years of age received the vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under 18 years of age received the vaccine) in a 16-year-old male patient who received mRNA-1273 (batch no. 039A21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Apr-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under 18 years of age received the vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under 18 years of age received the vaccine) outcome was unknown. The action taken with mRNA-1273 (Intramuscular) was unknown. For mRNA-1273 (Intramuscular), the reporter did not provide any causality assessments. Treatment medication were not provided. Concomitant medication were not provided.

Other Meds:

Current Illness:

ID: 1613149
Sex: F
Age:
State: DC

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain at the injection site; Swelling at the injection site; Redness at the injection site; slight arthralgia; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), ARTHRALGIA (slight arthralgia) and FATIGUE (tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 021B21A) for COVID-19 vaccination. No Medical History information was reported. On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced ARTHRALGIA (slight arthralgia) and FATIGUE (tiredness). On 28-Apr-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). On 07-Apr-2021, ARTHRALGIA (slight arthralgia) and FATIGUE (tiredness) had resolved. At the time of the report, VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. Patient concerned about a blood clot. Action taken with mRNA-1273 in response to the events was not Applicable. Company Comment : Based on the information provided which includes a temporal association between the use of mRNA-1273 vaccine and onset of the reported events, a causal relationship cannot be excluded. Injection site pain, injection site redness, injection site swelling, fatigue and arthralgia are consistent with the product known safety profile This case was linked to MOD-2021-101007 (Patient Link).; Sender's Comments: Based on the information provided which includes a temporal association between the use of mRNA-1273 vaccine and onset of the reported events, a causal relationship cannot be excluded. Injection site pain, injection site redness, injection site swelling, fatigue and arthralgia are consistent with the product known safety profile

Other Meds:

Current Illness:

ID: 1613150
Sex: M
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever for one day.; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever for one day.) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever for one day.). At the time of the report, PYREXIA (fever for one day.) had resolved. Action taken with mRNA-1273 in response to the events was not applicable. Concomitant and treatment medication was not reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1613151
Sex: F
Age: 31
State: CA

Vax Date: 05/02/2021
Onset Date: 05/02/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: lost her sense of taste; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (lost her sense of taste) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination. No medical history was provided. Concomitant products included AMOXICILLIN for an unknown indication. On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced AGEUSIA (lost her sense of taste). At the time of the report, AGEUSIA (lost her sense of taste) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Additional information was received from initial reporter and no new information

Other Meds: AMOXICILLIN

Current Illness:

ID: 1613152
Sex: M
Age: 62
State: NJ

Vax Date: 03/30/2021
Onset Date: 04/28/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fingers on Right Hand are Swollen; Peripheral Edema; severe skin rash, most severe on left leg, migrated to right arm; This spontaneous case was reported by a health care professional and describes the occurrence of PERIPHERAL SWELLING (Fingers on Right Hand are Swollen), OEDEMA PERIPHERAL (Peripheral Edema) and RASH (severe skin rash, most severe on left leg, migrated to right arm) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 018B21A) for COVID-19 vaccination. No medical history reported. On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced RASH (severe skin rash, most severe on left leg, migrated to right arm). On 30-Apr-2021, the patient experienced PERIPHERAL SWELLING (Fingers on Right Hand are Swollen) and OEDEMA PERIPHERAL (Peripheral Edema). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 29-Apr-2021 at a dose of 1 dosage form. At the time of the report, PERIPHERAL SWELLING (Fingers on Right Hand are Swollen), OEDEMA PERIPHERAL (Peripheral Edema) and RASH (severe skin rash, most severe on left leg, migrated to right arm) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided Action taken withmRNA-1273 in response to the events were not applicable

Other Meds:

Current Illness:

ID: 1613153
Sex: M
Age:
State: NY

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dry mouth 3 days after second dose; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (dry mouth 3 days after second dose) in a male patient of an unknown age who received mRNA-1273 for COVID-19 vaccination. No Medical History information was reported. In February 2021, the patient received second dose of mRNA-1273 (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. In February 2021, the patient experienced DRY MOUTH (dry mouth 3 days after second dose). At the time of the report, DRY MOUTH (dry mouth 3 days after second dose) outcome was unknown. Concomitant medications and treatment information was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1613154
Sex: F
Age: 58
State: CA

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: ice pick had gone thru her arm; arm was sore; very tired/exhausted; arm was killing her; sick; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (sick), FEELING ABNORMAL (ice pick had gone thru her arm), PAIN IN EXTREMITY (arm was sore), FATIGUE (very tired/exhausted) and VACCINATION SITE PAIN (arm was killing her) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 021C21A) for COVID-19 vaccination. No Medical History Information was reported. On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced MALAISE (sick), PAIN IN EXTREMITY (arm was sore), FATIGUE (very tired/exhausted) and VACCINATION SITE PAIN (arm was killing her). On 04-Apr-2021, the patient experienced FEELING ABNORMAL (ice pick had gone thru her arm). On 04-Apr-2021, MALAISE (sick) had resolved. At the time of the report, FEELING ABNORMAL (ice pick had gone thru her arm), PAIN IN EXTREMITY (arm was sore), FATIGUE (very tired/exhausted) and VACCINATION SITE PAIN (arm was killing her) outcome was unknown. Concomitant medication include Progesterone and estrogen patch. Treatment includes soaked in Epsom salt and Aspirin. This case was linked to MOD-2021-100460 (Patient Link).

Other Meds:

Current Illness:

ID: 1613155
Sex: F
Age:
State: NV

Vax Date: 04/29/2021
Onset Date: 04/29/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm felt hot at the injection site; Redness moved down her arm; Injection site got red; Injection site was raised a tiny bit; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Arm felt hot at the injection site), ERYTHEMA (Redness moved down her arm), INJECTION SITE ERYTHEMA (Injection site got red) and INJECTION SITE SWELLING (Injection site was raised a tiny bit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included METFORMIN for an unknown indication. On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced INJECTION SITE WARMTH (Arm felt hot at the injection site), ERYTHEMA (Redness moved down her arm), INJECTION SITE ERYTHEMA (Injection site got red) and INJECTION SITE SWELLING (Injection site was raised a tiny bit). At the time of the report, INJECTION SITE WARMTH (Arm felt hot at the injection site), ERYTHEMA (Redness moved down her arm), INJECTION SITE ERYTHEMA (Injection site got red) and INJECTION SITE SWELLING (Injection site was raised a tiny bit) outcome was unknown. Not Provided No treatment information was provided.

Other Meds: METFORMIN

Current Illness:

ID: 1613156
Sex: M
Age:
State: CT

Vax Date:
Onset Date: 04/30/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: patient was already fully vaccinated with Covid Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (patient was already fully vaccinated with Covid Vaccine) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced EXTRA DOSE ADMINISTERED (patient was already fully vaccinated with Covid Vaccine). On 30-Apr-2021, EXTRA DOSE ADMINISTERED (patient was already fully vaccinated with Covid Vaccine) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications and treatment information was not provided by the reporter. Reporter stated patient told the reporter that he was already fully vaccinated with a COVID vaccine (unknown manufacture) prior to receiving the dose on 30-Apr-2021.

Other Meds:

Current Illness:

ID: 1613157
Sex: F
Age: 69
State: FL

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: patient receiving the 2nd dose of the Moderna Covid-19 vaccine outside of the dosing window; Blood pressure elevated; This spontaneous case was reported by an other health care professional and describes the occurrence of BLOOD PRESSURE INCREASED (Blood pressure elevated) and OFF LABEL USE (patient receiving the 2nd dose of the Moderna Covid-19 vaccine outside of the dosing window) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038-K20A and 008C21A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE INCREASED (Blood pressure elevated) and OFF LABEL USE (patient receiving the 2nd dose of the Moderna Covid-19 vaccine outside of the dosing window). At the time of the report, BLOOD PRESSURE INCREASED (Blood pressure elevated) and OFF LABEL USE (patient receiving the 2nd dose of the Moderna Covid-19 vaccine outside of the dosing window) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: elevated (High) High. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. Concomitant medications: Taken but not listed Patient was told by her primary care provider not to get second dose as scheduled due to her blood pressure being elevated but has given the patient permission to receive it now.

Other Meds:

Current Illness: Hypertension

ID: 1613158
Sex: F
Age: 92
State: VA

Vax Date: 03/05/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (scheduled to receive her 2nd dose on 02apr2021) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. No medical history were provided by the reporter. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (scheduled to receive her 2nd dose on 02apr2021). At the time of the report, PRODUCT DOSE OMISSION ISSUE (scheduled to receive her 2nd dose on 02apr2021) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication information was provided by the reporter. No lab data has been provided by the reporter.

Other Meds:

Current Illness:

ID: 1613159
Sex: F
Age:
State:

Vax Date: 03/31/2021
Onset Date: 04/29/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: warmth over the left arm injection site; redness over the left arm injection site; pain over the left arm injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (warmth over the left arm injection site), VACCINATION SITE ERYTHEMA (redness over the left arm injection site) and VACCINATION SITE PAIN (pain over the left arm injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 030B21A) for COVID-19 vaccination. No Medical History information was reported. On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced VACCINATION SITE WARMTH (warmth over the left arm injection site), VACCINATION SITE ERYTHEMA (redness over the left arm injection site) and VACCINATION SITE PAIN (pain over the left arm injection site). At the time of the report, VACCINATION SITE WARMTH (warmth over the left arm injection site), VACCINATION SITE ERYTHEMA (redness over the left arm injection site) and VACCINATION SITE PAIN (pain over the left arm injection site) outcome was unknown. The patient went to her doctor and got treated with an antibiotic (unspecified). No concomitant medications were reported Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1613160
Sex: F
Age: 39
State: PA

Vax Date: 04/22/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Left Arm throbbing; Little bruise at injection site; This spontaneous case was reported by a patient and describes the occurrence of PAIN (Left Arm throbbing) and VACCINATION SITE BRUISING (Little bruise at injection site) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID -19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. Concurrent medical conditions included Breast feeding (Patient has reported to be a breast feeding mom.). On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID -19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Left Arm throbbing) and VACCINATION SITE BRUISING (Little bruise at injection site). At the time of the report, PAIN (Left Arm throbbing) and VACCINATION SITE BRUISING (Little bruise at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID -19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to MOD-2021-101422 (Parent-Child Link). See case MOD-2021-101422 for details regarding the child case.

Other Meds:

Current Illness: Breast feeding (Patient has reported to be a breast feeding mom.)

ID: 1613161
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Allergic attack; Missed her 2nd dose and its been 3months she had her 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of HYPERSENSITIVITY (Allergic attack) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed her 2nd dose and its been 3months she had her 1st dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Allergy. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Allergic attack) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed her 2nd dose and its been 3months she had her 1st dose). At the time of the report, HYPERSENSITIVITY (Allergic attack) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed her 2nd dose and its been 3months she had her 1st dose) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not reported. The patient received steroid shot several days after receiving the first dose of the Moderna COVID-19 vaccine for allergic attack. The patient missed her second dose and looking for second dose. First shot was administered 3 months ago.

Other Meds:

Current Illness: Allergy

ID: 1613162
Sex: F
Age: 76
State: IL

Vax Date: 03/03/2021
Onset Date: 04/18/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Patient just felt tired; Missed dose; 46 days after the first dose of the Moderna Covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (46 days after the first dose of the Moderna Covid-19 vaccine), FATIGUE (Patient just felt tired) and PRODUCT DOSE OMISSION ISSUE (Missed dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 025A21A) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (46 days after the first dose of the Moderna Covid-19 vaccine) and PRODUCT DOSE OMISSION ISSUE (Missed dose). On 19-Apr-2021, the patient experienced FATIGUE (Patient just felt tired). The patient was treated with PARACETAMOL (TYLENOL) (oral) for Fatigue, at a dose of 500 mg. On 18-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (46 days after the first dose of the Moderna Covid-19 vaccine) and PRODUCT DOSE OMISSION ISSUE (Missed dose) had resolved. On 20-Apr-2021, FATIGUE (Patient just felt tired) had resolved. Concomitant product use was not provided by the reporter. Action taken with mRNA-1273 in response to the events was not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1613163
Sex: F
Age:
State: IN

Vax Date: 04/24/2021
Onset Date: 04/24/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site warm; lnjection site little bumps almost like blisters; Injection site itchy; Area where she got the vaccine was sensitive; Injection site swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site warm), VACCINATION SITE VESICLES (lnjection site little bumps almost like blisters), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE PAIN (Area where she got the vaccine was sensitive) and VACCINATION SITE SWELLING (Injection site swollen) in a 58-year-old female patient who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch no. 016C21A) for COVID-19 vaccination. No Medical History information was reported. On 24-Apr-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Injection site warm), VACCINATION SITE VESICLES (lnjection site little bumps almost like blisters), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE PAIN (Area where she got the vaccine was sensitive) and VACCINATION SITE SWELLING (Injection site swollen). At the time of the report, VACCINATION SITE WARMTH (Injection site warm), VACCINATION SITE VESICLES (lnjection site little bumps almost like blisters), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE PAIN (Area where she got the vaccine was sensitive) and VACCINATION SITE SWELLING (Injection site swollen) outcome was unknown. The action taken with mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) was unknown. No treatment information was provided. Concomitant medication included thyroid medication (unspecified).

Other Meds:

Current Illness:

ID: 1613164
Sex: F
Age: 82
State: NY

Vax Date: 02/18/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: On and off headache that sometimes radiates at the back or in the front; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (On and off headache that sometimes radiates at the back or in the front) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (On and off headache that sometimes radiates at the back or in the front). At the time of the report, HEADACHE (On and off headache that sometimes radiates at the back or in the front) outcome was unknown. No relevant concomitant medications were reported. No treatment information was reported.

Other Meds:

Current Illness:

ID: 1613165
Sex: M
Age: 57
State: TX

Vax Date: 04/01/2021
Onset Date: 05/01/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue/tired; Headache; Chills; Fever; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue/tired), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Fever) and VACCINATION SITE PAIN (Pain at injection site) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 008BT1A) for COVID-19 vaccination. No Medical History information was reported. On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-May-2021, the patient experienced FATIGUE (Fatigue/tired), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Fever) and VACCINATION SITE PAIN (Pain at injection site). At the time of the report, FATIGUE (Fatigue/tired), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Fever) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1613166
Sex: F
Age: 43
State: GA

Vax Date: 03/24/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Full body twitches; That are painful; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (Full body twitches) and PAIN (That are painful) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. No medical history was reported. Concomitant products included GABAPENTIN, HYDROCORTISONE, LEFLUNOMIDE (FLUDART), CELECOXIB (CELEBREX), MONTELUKAST SODIUM (SINGULAIR), POTASSIUM, RANOLAZINE, DULOXETINE, ACARBOSE and OMEPRAZOLE for an unknown indication. On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE TWITCHING (Full body twitches) and PAIN (That are painful). At the time of the report, MUSCLE TWITCHING (Full body twitches) and PAIN (That are painful) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication also included Methyl Carbinol and Piperamide for unknown indication. No treatment information was provided.

Other Meds: GABAPENTIN; HYDROCORTISONE; FLUDART; CELEBREX; SINGULAIR; POTASSIUM; RANOLAZINE; DULOXETINE; ACARBOSE; OMEPRAZOLE

Current Illness:

ID: 1613167
Sex: F
Age: 32
State: TX

Vax Date: 05/01/2021
Onset Date: 05/02/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; Nosebleed; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and EPISTAXIS (Nosebleed) in a 32-year-old female patient who received mRNA-1273 (batch no. 04SA21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included FLUTAMIDE (PROFAMID) for Blood pressure abnormal. On 01-May-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced DIZZINESS (Dizziness) and EPISTAXIS (Nosebleed). At the time of the report, DIZZINESS (Dizziness) and EPISTAXIS (Nosebleed) outcome was unknown. The action taken with mRNA-1273 (Intramuscular) was unknown. for mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessment. No treatment details were not reported.

Other Meds: PROFAMID

Current Illness:

ID: 1613168
Sex: F
Age: 64
State: FL

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: the Moderna vaccine has cured my Type II diabetes; some arm soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (some arm soreness at injection site) and THERAPEUTIC RESPONSE UNEXPECTED (the Moderna vaccine has cured my Type II diabetes) in a 64-year-old female patient who received mRNA-1273 (batch nos. 047A21A and 021B21A) for COVID-19 vaccination. The patient's past medical history included Type 2 diabetes mellitus. On 25-Mar-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced VACCINATION SITE PAIN (some arm soreness at injection site). On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (the Moderna vaccine has cured my Type II diabetes). On 26-Mar-2021, VACCINATION SITE PAIN (some arm soreness at injection site) had resolved. At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (the Moderna vaccine has cured my Type II diabetes) outcome was unknown. For mRNA-1273 (Intramuscular), the reporter did not provide any causality assessments. treatment information not provided. This case was linked to MOD-2021-101376 (Patient Link).

Other Meds: METFORMIN; GLYBURIDE

Current Illness:

ID: 1613169
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: felt sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (felt sick) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (felt sick). At the time of the report, ILLNESS (felt sick) outcome was unknown. No concomitant medications reported by investigator No treatment medications provided by the reporter. Action taken with mRNA-1273 in response to the event was not applicable. Symptom text: Patient reported that when she saw her Doctor her Doctor told her that he had received both doses of his Moderna Covid-19 vaccine and that the Doctor felt sick after each dose. I am reporting this as a limited Adverse Event and the manufacturer of the vaccine is unknown. Other Patient specific and product specific vaccine information is unknown at this time. This case was linked to US-MODERNATX, INC.-MOD-2021-103953 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-103953:

Other Meds:

Current Illness:

ID: 1613170
Sex: F
Age: 43
State: NY

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lost feeling in both legs; Little dizziness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 30-Apr-2021 and was forwarded to Moderna on 30-Apr-2021. This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Lost feeling in both legs) and DIZZINESS (Little dizziness) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. Concomitant products included MULTIVITAMINS & MINERALS PLUS LUTEIN, BUPROPION HYDROCHLORIDE (WELLBUTRIN) and GABAPENTIN for an unknown indication. On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced HYPOAESTHESIA (Lost feeling in both legs) and DIZZINESS (Little dizziness). On 23-Apr-2021, HYPOAESTHESIA (Lost feeling in both legs) and DIZZINESS (Little dizziness) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment information was reported.

Other Meds: MULTIVITAMINS & MINERALS PLUS LUTEIN; WELLBUTRIN; GABAPENTIN

Current Illness:

ID: 1613171
Sex: F
Age: 20
State: OH

Vax Date: 04/01/2021
Onset Date: 04/29/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Burning sensation on rash; Face swollen; Rash on arm/ Rash started spreading/ Rash spreaded throughout body/ Painful rash; Fever; Rash became itchier; This spontaneous case was reported by a non-health professional and describes the occurrence of BURNING SENSATION (Burning sensation on rash), RASH PRURITIC (Rash became itchier), SWELLING FACE (Face swollen), RASH (Rash on arm/ Rash started spreading/ Rash spreaded throughout body/ Painful rash) and PYREXIA (Fever) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006C21A and 025B21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced RASH PRURITIC (Rash became itchier), RASH (Rash on arm/ Rash started spreading/ Rash spreaded throughout body/ Painful rash) and PYREXIA (Fever). On 01-May-2021, the patient experienced BURNING SENSATION (Burning sensation on rash) and SWELLING FACE (Face swollen). At the time of the report, BURNING SENSATION (Burning sensation on rash), RASH PRURITIC (Rash became itchier) and SWELLING FACE (Face swollen) outcome was unknown, RASH (Rash on arm/ Rash started spreading/ Rash spreaded throughout body/ Painful rash) had not resolved and PYREXIA (Fever) had resolved. The patient was not taking any concomitant medications. The patient has not sought medical attention and no treatment information was provided. This case was linked to MOD-2021-100584 (Patient Link).

Other Meds:

Current Illness:

ID: 1613172
Sex: F
Age:
State: NJ

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Can't lift arm/ put arm backward; can't hook a bra/ can't zip pants/ can't move arm above head with the injection arm; can't lay on arm; Tendonitis; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MOBILITY DECREASED (Can't lift arm/ put arm backward), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (can't hook a bra/ can't zip pants/ can't move arm above head with the injection arm), PAIN IN EXTREMITY (can't lay on arm) and TENDONITIS (Tendonitis) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 026L20A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (Can't lift arm/ put arm backward), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (can't hook a bra/ can't zip pants/ can't move arm above head with the injection arm), PAIN IN EXTREMITY (can't lay on arm) and TENDONITIS (Tendonitis). At the time of the report, MOBILITY DECREASED (Can't lift arm/ put arm backward), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (can't hook a bra/ can't zip pants/ can't move arm above head with the injection arm), PAIN IN EXTREMITY (can't lay on arm) and TENDONITIS (Tendonitis) had not resolved. No concomitant medications were provided. The patient was given the diagnosis of Tendonitis by the HCP.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1613173
Sex: F
Age: 61
State: OH

Vax Date: 01/06/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: affected my hair; This spontaneous case was reported by a consumer and describes the occurrence of HAIR DISORDER (affected my hair) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HAIR DISORDER (affected my hair). At the time of the report, HAIR DISORDER (affected my hair) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Blood testosterone: normal (normal) normal. On 24-Feb-2021, Haemoglobin: normal (normal) normal. On 24-Feb-2021, Thyroid function test: normal (normal) normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No corrective treatment was reported by the patient. This case was linked to US-MODERNATX, INC.-MOD-2021-100532 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-100532:second dose

Other Meds:

Current Illness:

ID: 1613174
Sex: F
Age: 26
State: CT

Vax Date: 03/27/2021
Onset Date: 04/24/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: COVID-19 Positive after first dose; Tested COVID-19 positive so did not receive the vaccine second dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19 Positive after first dose) and INTENTIONAL PRODUCT USE ISSUE (Tested COVID-19 positive so did not receive the vaccine second dose) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced COVID-19 (COVID-19 Positive after first dose) and INTENTIONAL PRODUCT USE ISSUE (Tested COVID-19 positive so did not receive the vaccine second dose). On 24-Apr-2021, INTENTIONAL PRODUCT USE ISSUE (Tested COVID-19 positive so did not receive the vaccine second dose) had resolved. At the time of the report, COVID-19 (COVID-19 Positive after first dose) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Apr-2021, SARS-CoV-2 test: inconclusive (Positive) inconclusive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided. 21Apr2021 and had not received the vaccine.; Sender's Comments: Very limited information regarding the events has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1613175
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe headache; body aches; This spontaneous case was reported by an other and describes the occurrence of HEADACHE (severe headache) and MYALGIA (body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (severe headache) and MYALGIA (body aches). At the time of the report, HEADACHE (severe headache) and MYALGIA (body aches) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1613176
Sex: M
Age: 74
State: NY

Vax Date: 04/23/2021
Onset Date: 03/23/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Could not raise arm; Arm soreness; Body malaise; Chills; Low grade fever 99.3F; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), MALAISE (Body malaise), MUSCULAR WEAKNESS (Could not raise arm), PYREXIA (Low grade fever 99.3F) and CHILLS (Chills) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 (developed positive antibodies) in September 2020. On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced PYREXIA (Low grade fever 99.3F). On 23-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness), MALAISE (Body malaise) and CHILLS (Chills). On an unknown date, the patient experienced MUSCULAR WEAKNESS (Could not raise arm). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 24-Apr-2021, PAIN IN EXTREMITY (Arm soreness), MALAISE (Body malaise), PYREXIA (Low grade fever 99.3F) and CHILLS (Chills) had resolved. At the time of the report, MUSCULAR WEAKNESS (Could not raise arm) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, Body temperature: 99.3 degree f (Low) Low grade fever 99.3 degree F On 24-MAR-2021 recovered.. On 28-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Patient Quest diagnostics re-ran sample and confirmed it was negative for viral load and therefore the PCR test was false positive. he put off the colonoscopy due to false positive . Terrible arm pain/severe arm pain ,AE Preferred Contact Updated, AE details updated were given as events This case was linked to MOD-2021-100770 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow-Up received on 14-JUN-2021 and new AE event updated On 27-Jul-2021: Follow up received on 27 JUL 2021 included no new information.

Other Meds:

Current Illness:

ID: 1613177
Sex: F
Age: 73
State:

Vax Date: 04/28/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness at the injection site that is size of baseball; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at the injection site that is size of baseball) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0021C21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included LEVOTHYROXINE for an unknown indication. On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site that is size of baseball). The patient was treated with PARACETAMOL (TYLENOL) for Vaccination site erythema, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE ERYTHEMA (Redness at the injection site that is size of baseball) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment details included Tylenol.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1613178
Sex: F
Age: 67
State: MI

Vax Date: 04/30/2021
Onset Date: 04/30/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: lightheadedness; vaccination site was inflammed; injection site was tender/ injection site was painful with pain scale of 6; fever with temperature of 100.2F and 103.2F; Body aches; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheadedness), VACCINATION SITE INFLAMMATION (vaccination site was inflammed), VACCINATION SITE PAIN (injection site was tender/ injection site was painful with pain scale of 6), PYREXIA (fever with temperature of 100.2F and 103.2F) and MYALGIA (Body aches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Allergy to molds, Allergy to animal dander and Pollen allergy. Concomitant products included OLOPATADINE and OLOPATADINE for Allergy, MULTIVITAMINS [VITAMINS NOS], L-THYROXIN [LEVOTHYROXINE], SIMVASTATIN, PREGABALIN and FLUTICASONE FUROATE (FLONASE SENSIMIST ALLERGY RELIEF) for an unknown indication. On 30-Apr-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced DIZZINESS (lightheadedness), VACCINATION SITE INFLAMMATION (vaccination site was inflammed), VACCINATION SITE PAIN (injection site was tender/ injection site was painful with pain scale of 6), PYREXIA (fever with temperature of 100.2F and 103.2F), MYALGIA (Body aches), CHILLS (chills) and HEADACHE (headache). At the time of the report, DIZZINESS (lightheadedness), VACCINATION SITE INFLAMMATION (vaccination site was inflammed), VACCINATION SITE PAIN (injection site was tender/ injection site was painful with pain scale of 6), PYREXIA (fever with temperature of 100.2F and 103.2F), MYALGIA (Body aches), CHILLS (chills) and HEADACHE (headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Apr-2021, Body temperature: 100.2 (High) Fever with temperature of 100.2 F then at around 5:30 P.M it was 103.2 F. On 01-May-2021, Body temperature: fever was down to 100.8f (High) fever was down to 100.8F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient's concomitant also include an allergy pill (unspecified). The patient applied ice pack for 20 minutes on affected arm.

Other Meds: MULTIVITAMINS [VITAMINS NOS]; L-THYROXIN [LEVOTHYROXINE]; SIMVASTATIN; PREGABALIN; OLOPATADINE; FLONASE SENSIMIST ALLERGY RELIEF; OLOPATADINE

Current Illness: Allergy to animal dander; Allergy to molds; Pollen allergy

ID: 1613179
Sex: F
Age: 60
State: MD

Vax Date: 03/25/2021
Onset Date: 04/22/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Achy after 2nd dose; Prickly skin after 2nd dose; Less joint pain, including hip and feet, since 2nd dose; Chills; diarrhea; fever of 100.4/fever lasted 36 hours; headache again after the second shot/headache and it came and went; body aches again after the second shot/body aches lasted 3 days; nausea; Injection site arm pain after both doses; unbearable fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy after 2nd dose), SKIN IRRITATION (Prickly skin after 2nd dose), DIARRHOEA (diarrhea), PYREXIA (fever of 100.4/fever lasted 36 hours) and HEADACHE (headache again after the second shot/headache and it came and went) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced DIARRHOEA (diarrhea), PYREXIA (fever of 100.4/fever lasted 36 hours), HEADACHE (headache again after the second shot/headache and it came and went), MYALGIA (body aches again after the second shot/body aches lasted 3 days), NAUSEA (nausea), VACCINATION SITE PAIN (Injection site arm pain after both doses) and FATIGUE (unbearable fatigue). On an unknown date, the patient experienced PAIN (Achy after 2nd dose), SKIN IRRITATION (Prickly skin after 2nd dose), ARTHRALGIA (Less joint pain, including hip and feet, since 2nd dose) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and ALUMINIUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETICONE (PEPSID) at an unspecified dose and frequency. At the time of the report, PAIN (Achy after 2nd dose), SKIN IRRITATION (Prickly skin after 2nd dose), DIARRHOEA (diarrhea), PYREXIA (fever of 100.4/fever lasted 36 hours), HEADACHE (headache again after the second shot/headache and it came and went), MYALGIA (body aches again after the second shot/body aches lasted 3 days), NAUSEA (nausea), VACCINATION SITE PAIN (Injection site arm pain after both doses), FATIGUE (unbearable fatigue), ARTHRALGIA (Less joint pain, including hip and feet, since 2nd dose) and CHILLS (Chills) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2021, Body temperature increased: 100.4 (High) High. On an unknown date, Body temperature increased: 101.5 (High) Fever of up to 101.5 degrees F for 12 hours. On 22-Apr-2021, after second shot drank a lot of water as a treatment. No concomitant information was provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow up document was attached on 01-Jun-201 which contains updated events : Fatigue, Arthralgia, Chills, Skin Irritation and Pain.

Other Meds:

Current Illness:

ID: 1613180
Sex: F
Age: 31
State:

Vax Date: 04/01/2021
Onset Date: 04/29/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: massive excruciating headache from eyes to the back of her head; chills; burning sensation in her veins; slept all day; pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning sensation in her veins), HYPERSOMNIA (slept all day), VACCINATION SITE PAIN (pain in the arm), CHILLS (chills) and HEADACHE (massive excruciating headache from eyes to the back of her head) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 007B21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (pain in the arm). On 30-Apr-2021, the patient experienced BURNING SENSATION (burning sensation in her veins), HYPERSOMNIA (slept all day) and CHILLS (chills). On 01-May-2021, the patient experienced HEADACHE (massive excruciating headache from eyes to the back of her head). The patient was treated with PARACETAMOL (TYLENOL) from 29-Apr-2021 to 30-Apr-2021 for Pain, at an unspecified dose and frequency. At the time of the report, BURNING SENSATION (burning sensation in her veins), HYPERSOMNIA (slept all day), VACCINATION SITE PAIN (pain in the arm), CHILLS (chills) and HEADACHE (massive excruciating headache from eyes to the back of her head) outcome was unknown. The action taken with mRNA-1273(Moderna COVID-19 Vaccine) was not applicable No concomitant medications were reported This case was linked to MOD-2021-100457 (Patient Link).

Other Meds:

Current Illness:

ID: 1613181
Sex: F
Age:
State: CA

Vax Date: 04/23/2021
Onset Date: 04/30/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of erythematous rash (red bumps on arm) in a 26-year-old female patient who received mRNA-1273 for COVID-19 vaccination. No medical history reported. On Apr 23, 2021, patient received dose of mRNA-1273, intramuscular; 1 dosage form. On Apr 30, 2021, patient experienced erythematous rash (red bumps on arm). At the time of the report, erythematous rash (red bumps on arm) outcome: unknown. The action taken with mRNA-1273, intramuscular: unknown. No concomitant medication or treatment information reported/provided.

Other Meds:

Current Illness:

ID: 1613182
Sex: F
Age:
State: NY

Vax Date: 01/13/2021
Onset Date: 01/18/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: nurse employed "pinched her arm at the injection site, felt like the needle didn't enter her muscle,; itching around injection site; This spontaneous case was reported by a consumer and describes the occurrence of MEDICATION ERROR (nurse employed "pinched her arm at the injection site, felt like the needle didn't enter her muscle,) and INJECTION SITE PRURITUS (itching around injection site) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 012M20A) for COVID-19 vaccination. The patient's past medical history included Pulmonary hypertension. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jan-2021, the patient experienced INJECTION SITE PRURITUS (itching around injection site). On 09-Feb-2021, the patient experienced MEDICATION ERROR (nurse employed "pinched her arm at the injection site, felt like the needle didn't enter her muscle,). At the time of the report, MEDICATION ERROR (nurse employed "pinched her arm at the injection site, felt like the needle didn't enter her muscle,) and INJECTION SITE PRURITUS (itching around injection site) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, SARS-CoV-2 antibody test: negative (Negative) No antibodies on test. Concomitant medications were not provided. Treatment medications was not given.

Other Meds:

Current Illness:

ID: 1613183
Sex: M
Age: 64
State: WA

Vax Date: 02/25/2021
Onset Date: 03/04/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Disoriented; Ringing in my ears; Numbing of my lips; Numbing of my left cheek/Numbing of my left hand; Chest pains; High blood pressure; Lightheadedness worse; Fatigue; Migraine on the left side of my head; shortness of Breath after running; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN, HYPERTENSION, MIGRAINE, DISORIENTATION, and TINNITUS in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced DYSPNOEA EXERTIONAL (shortness of Breath after running). On 26-Mar-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MIGRAINE (Migraine on the left side of my head). On 27-Mar-2021, the patient experienced CHEST PAIN, HYPERTENSION, DISORIENTATION, TINNITUS, HYPOAESTHESIA ORAL, HYPOAESTHESIA, DIZZINESS, and FATIGUE. On 27-Mar-2021, MIGRAINE had resolved. On 09-Apr-2021, CHEST PAIN had resolved. At the time of the report, HYPERTENSION, DISORIENTATION, TINNITUS, HYPOAESTHESIA ORAL, HYPOAESTHESIA (Numbing of my left cheek/Numbing of my left hand), DYSPNOEA EXERTIONAL, and FATIGUE outcome was unknown and DIZZINESS (Lightheadedness worse) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: normal. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not reported. Treatment information was not provided. This case was linked to US-MODERNATX, INC-MOD-2021-100429. Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: New lab test EKG and heart test were reported. Sender's Comments: Based on current available information and the temporal association between product use and the start date of events a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1613184
Sex: F
Age: 26
State: OH

Vax Date: 04/01/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: she had really bad pain in her arm to the point where she couldn't lift her arm; couldn't lift her arm; also has a rash, raised and red, slowly spreading instead of getting smaller, surface area has been getting bigger since Thursday; Left sided chest pain, sharp muscle pain in the chest, heart is really sharp and tight; everything on the left side hurts; bad migraine; dizziness; nausea; Generalized soreness and pain on the left side of her body; muscle pain; This spontaneous case was reported by an other and describes the occurrence of PAIN IN EXTREMITY (she had really bad pain in her arm to the point where she couldn't lift her arm), MOBILITY DECREASED (couldn't lift her arm), RASH ERYTHEMATOUS (also has a rash, raised and red, slowly spreading instead of getting smaller, surface area has been getting bigger since Thursday), CHEST PAIN (Left sided chest pain, sharp muscle pain in the chest, heart is really sharp and tight) and PAIN (everything on the left side hurts) in a female patient of an unknown age who received mRNA-1273 (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 01-Apr-2021, the patient received dose of mRNA-1273 (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (she had really bad pain in her arm to the point where she couldn't lift her arm), MOBILITY DECREASED (couldn't lift her arm), RASH ERYTHEMATOUS (also has a rash, raised and red, slowly spreading instead of getting smaller, surface area has been getting bigger since Thursday), CHEST PAIN (Left sided chest pain, sharp muscle pain in the chest, heart is really sharp and tight), PAIN (everything on the left side hurts), MIGRAINE (bad migraine), DIZZINESS (dizziness), NAUSEA (nausea), MYALGIA (Generalized soreness and pain on the left side of her body) and MYALGIA (muscle pain). At the time of the report, PAIN IN EXTREMITY (she had really bad pain in her arm to the point where she couldn't lift her arm), MOBILITY DECREASED (couldn't lift her arm), RASH ERYTHEMATOUS (also has a rash, raised and red, slowly spreading instead of getting smaller, surface area has been getting bigger since Thursday), CHEST PAIN (Left sided chest pain, sharp muscle pain in the chest, heart is really sharp and tight), PAIN (everything on the left side hurts), MIGRAINE (bad migraine), DIZZINESS (dizziness), NAUSEA (nausea), MYALGIA (Generalized soreness and pain on the left side of her body) and MYALGIA (muscle pain) had not resolved. The action taken with mRNA-1273 (Unknown Route) was unknown. No concomitant medication details were reported. No Treatment Medications were reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1613185
Sex: F
Age:
State: CA

Vax Date: 04/01/2021
Onset Date:
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Placed in a mental institution; Will miss second dose and for 30 days she will be in mental institution; This spontaneous case was reported by a consumer and describes the occurrence of MENTAL DISORDER (Placed in a mental institution) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Will miss second dose and for 30 days she will be in mental institution) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENTAL DISORDER (Placed in a mental institution) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Will miss second dose and for 30 days she will be in mental institution). At the time of the report, MENTAL DISORDER (Placed in a mental institution) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Will miss second dose and for 30 days she will be in mental institution) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product was not provided by the reporter. Treatment information was not provided

Other Meds:

Current Illness:

ID: 1613186
Sex: F
Age:
State: TX

Vax Date: 01/27/2021
Onset Date: 02/27/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: feeling lethargic; arm began to hurt; Scabs ich like crazy; Bumps; sporadic rash under bra strap and across shoulders; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (feeling lethargic), PAIN IN EXTREMITY (arm began to hurt), RASH PRURITIC (Scabs ich like crazy), SWELLING (Bumps) and RASH (sporadic rash under bra strap and across shoulders) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 004M20A) for COVID-19 vaccination. The patient's past medical history included Neuropathy (in arms and legs due to spinal fusion.) and Weight loss (138lbs to 118lbs .). Concomitant products included CALCIUM, MAGNESIUM, ZINC and ASCORBIC ACID (VITAMIN C ACID) for an unknown indication. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced LETHARGY (feeling lethargic), PAIN IN EXTREMITY (arm began to hurt), RASH PRURITIC (Scabs ich like crazy), SWELLING (Bumps) and RASH (sporadic rash under bra strap and across shoulders). At the time of the report, LETHARGY (feeling lethargic), PAIN IN EXTREMITY (arm began to hurt), RASH PRURITIC (Scabs ich like crazy) and SWELLING (Bumps) outcome was unknown and RASH (sporadic rash under bra strap and across shoulders) had resolved. Treatment medication included Hydrocortisone twice daily Action taken with mRNA-1273 in response to the events were Not Applicable This case was linked to MOD-2021-025222 (Patient Link).

Other Meds: CALCIUM; MAGNESIUM; ZINC; VITAMIN C ACID

Current Illness:

ID: 1613187
Sex: F
Age: 42
State: IL

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hard to breath; Fever; Body ache; Tiredness; This spontaneous case was reported by a non-health professional and describes the occurrence of DYSPNOEA (Hard to breath), PYREXIA (Fever), FATIGUE (Tiredness) and ARTHRALGIA (Body ache) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 006C21A) for COVID-19 immunisation. No Medical History information was reported. On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced FATIGUE (Tiredness). On 01-May-2021, the patient experienced DYSPNOEA (Hard to breath), PYREXIA (Fever) and ARTHRALGIA (Body ache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Hard to breath), PYREXIA (Fever), FATIGUE (Tiredness) and ARTHRALGIA (Body ache) outcome was unknown. No concomitant medication details was reported.

Other Meds:

Current Illness:

ID: 1613188
Sex: F
Age:
State: MO

Vax Date: 04/29/2021
Onset Date: 04/29/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 48-year-old female patient who received mRNA-1273 (batch no. 011M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 29-Apr-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. mRNA-1273 (Intramuscular) dosing remained unchanged.

Other Meds:

Current Illness:

ID: 1613189
Sex: F
Age: 66
State: NJ

Vax Date: 03/16/2021
Onset Date: 04/13/2021
Rec V Date: 08/22/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: vomiting for 20 times in 3 hours time; continuous ringing in her ears; problem with her gall bladder which elevated after the vaccine; big toe is red; toe next to big toe is purplish; her eye movements are off; Hives; Blurry eyes; Smashed her feet; Palpitation; Coughing; Respiratory Mucus; Respiratory issue; Redness of face; Red and burning eyes; Itchiness of face; Redness of chest; Itchiness of chest; Diarrhea; Redness of lips; itchiness of lips; severe chest pain; tingling lips; Trouble standing; Felt an elephant on chest; Urinary incontinence; Dizziness; Burning legs; vertigo; trouble standing; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness of face), EYE IRRITATION (Red and burning eyes), PRURITUS (Itchiness of face), CHEST DISCOMFORT (Redness of chest) and CHEST PAIN (Itchiness of chest) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included ZILEUTON and HYDROXYZINE for Allergy. On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced ERYTHEMA (Redness of face). 13-Apr-2021, the patient experienced EYE IRRITATION (Red and burning eyes), PRURITUS (Itchiness of face), CHEST DISCOMFORT (Redness of chest), CHEST PAIN (Itchiness of chest), DIARRHOEA (Diarrhea), LIP ERYTHEMA (Redness of lips), LIP PRURITUS (itchiness of lips), CHEST PAIN (severe chest pain), PARAESTHESIA ORAL (tingling lips), DYSSTASIA (Trouble standing), CHEST DISCOMFORT (Felt an elephant on chest), URINARY INCONTINENCE (Urinary incontinence), DIZZINESS (Dizziness), LIMB DISCOMFORT (Burning legs), VERTIGO (vertigo) and GAIT DISTURBANCE (trouble standing). On an unknown date, the patient experienced VOMITING (vomiting for 20 times in 3 hours time), TINNITUS (continuous ringing in her ears), GALLBLADDER DISORDER (problem with her gall bladder which elevated after the vaccine), ERYTHEMA (big toe is red), NAIL DISCOLOURATION (toe next to big toe is purplish), EYE MOVEMENT DISORDER (her eye movements are off), URTICARIA (Hives), VISION BLURRED (Blurry eyes), LIMB DISCOMFORT (Smashed her feet), PALPITATIONS (Palpitation), COUGH (Coughing), RESPIRATORY DISORDER (Respiratory Mucus) and RESPIRATORY DISORDER (Respiratory issue). On 14-Apr-2021, PRURITUS (Itchiness of face), CHEST DISCOMFORT (Redness of chest), LIMB DISCOMFORT (Burning legs), VERTIGO (vertigo) and GAIT DISTURBANCE (trouble standing) had resolved. At the time of the report, ERYTHEMA (Redness of face), EYE IRRITATION (Red and burning eyes), CHEST PAIN (Itchiness of chest), DIARRHOEA (Diarrhea), LIP ERYTHEMA (Redness of lips), LIP PRURITUS (itchiness of lips), CHEST PAIN (severe chest pain), PARAESTHESIA ORAL (tingling lips), DYSSTASIA (Trouble standing), CHEST DISCOMFORT (Felt an elephant on chest), URINARY INCONTINENCE (Urinary incontinence), DIZZINESS (Dizziness), VOMITING (vomiting for 20 times in 3 hours time), TINNITUS (continuous ringing in her ears), GALLBLADDER DISORDER (problem with her gall bladder which elevated after the vaccine), ERYTHEMA (big toe is red), NAIL DISCOLOURATION (toe next to big toe is purplish), EYE MOVEMENT DISORDER (her eye movements are off), URTICARIA (Hives), VISION BLURRED (Blurry eyes), LIMB DISCOMFORT (Smashed her feet), PALPITATIONS (Palpitation), COUGH (Coughing), RESPIRATORY DISORDER (Respiratory Mucus) and RESPIRATORY DISORDER (Respiratory issue) outcome was unknown. Treatment medications at the ER (emergency room) included intra-venous corticosteroids. The patient also reported that she took Benadryl (diphenhydramine), prior to going to the ER. The patient reported that she consulted various doctors which included 13 primary care physicians, neurologists, asthma and allergy doctors and a neuro-optometrist. Treatment medications included hydroxyzine, Benadryl, methylprednisolone, cetirizine and albuterol inhaler. This case was linked to MOD21-084318 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: No specific follow-up information recorded.

Other Meds: ZILEUTON; HYDROXYZINE

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm